Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a new build of the site rather than an alteration to study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:55:35.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, without changing the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:40:52.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2 and the previous revision v3.5.0 has been removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:35:20.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:08:57.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; Removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:52:52.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed Revision: v3.4.1 notice about government funding and operating status.
    Difference
    0.4%
    Check dated 2026-02-11T12:14:27.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.